Cold Chain, Warm Margins: Why US Pharma Exporters Are Paying a Premium for Compliance Theater
US pharmaceutical and perishable goods exporters are absorbing enormous cold chain costs they rarely scrutinize — from redundant monitoring technology to duplicative certifications across overlapping regulatory regimes. Meanwhile, competitors operating out of Mexico and Portugal have systematically stripped those costs away. The margin gap is widening, and most US exporters have yet to notice.